KLRK1 and neoplasm: Blocking NKG2D in Ovalbumin (OVA)-immunized mice delayed the growth of B16OVA-Luc2 tumors (a luciferase-expressing mouse melanoma cell line) and increased the presence of OVA-specific CD8+ T cells infiltrating the tumor [57].